ArticleScientific reports2025
Decision tree-based machine learning methods for identifying colorectal cancer-associated microRNA signatures and their regulatory networks.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The result prediction of fluorescence in situ hybridization for breast cancer patients based on machine learning and deep learning models: a multicenter study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Artificial intelligence-based miRNA analysis for precision oncology: diagnostic and prognostic insights.Frontiers in molecular biosciences · 2026Review
- RNA-based therapies for colorectal cancer: targeting the β-catenin pathway via microbiota -modulated miRNAs.Frontiers in molecular biosciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify candidate diagnostic miRNAs from the serum of colorectal cancer (CRC) patients using Boruta, a wrapper-based feature selection technique, in combination with decision tree-based machine learning methods. We analyzed three serum miRNA expression profile datasets from the gene expression omnibus (GEO) database to identify differentially expressed miRNAs common to both cancerous and non-cancerous samples. The GSE106817 dataset, comprising 2568 miRNAs, was used to train our models. The Boruta machine learning feature selection method was applied to identify robust and significant miRNAs associated with CRC in the training cohort. Next, random forest and XGBoost models were trained using the selected miRNAs. To validate the predictive efficacy of the identified candidate miRNAs, we tested them against two independent datasets (GSE113486 and GSE113740). Finally, we performed ontology analysis and constructed a regulatory network to explore the potential links between the selected miRNAs and CRC development. The GSE106817 dataset included 115 CRC patients and 2759 non-cancerous samples. Using Boruta, we identified 146 miRNAs as potential biomarkers for CRC diagnosis. Among these, the highest-scoring miRNAs were: hsa-miR-1228-5p, hsa-miR-6787-5p, hsa-miR-1343-3p, hsa-miR-6717-5p, hsa-miR-3184-5p, hsa-miR-1246, hsa-miR-4706, hsa-miR-8073, hsa-miR-5100. The machine learning models achieved an AUC of 100% when tested on the internal dataset. Additionally, the external validation datasets showed an AUC exceeding 95%, confirming the robustness and reliability of our findings. Furthermore, functional annotation analysis revealed the involvement of several miRNA-mediated pathways in the pathogenesis of CRC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.